Sign in

CIK 0001497253

  • Non-accelerated filer
  • Smaller reporting company

VivoSim Labs, INC.

Sign in to watch
Ticker
VIVS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
271488943
Phone
+1 858-224-1000
Business address
11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO, CA, 92121
Former names
ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.
Open-market buys, last 90 days
$2,804
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$2,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lialin Tony Serge +$3K Chief Commercial Officer 1 filing

Reading 60 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-06-27 Presnell Sharon Collins Chief Scientific Officer Grant or award +200,000 299,188
2017-06-27 KUSSMAN CRAIG Chief Financial Officer Grant or award +220,000 352,000
2017-06-27 Gallant Paul General Manager Grant or award +160,000 202,738
2017-06-27 David Eric CSO & EVP Pre-Clinical Dev Grant or award +190,000 890,703
2017-06-27 Bush Jennifer General Counsel & Secretary Grant or award +35,000 79,951
2017-06-27 Bush Jennifer General Counsel & Secretary Grant or award +190,000 269,951
2017-05-16 Gallant Paul General Manager Shares withheld for taxes −1,317 $2.86 $4K 42,738
2017-05-16 David Eric CSO & EVP Pre-Clinical Dev Shares withheld for taxes −1,263 $2.86 $4K 700,703
2017-05-16 Bush Jennifer General Counsel & Secretary Shares withheld for taxes −1,235 $2.86 $4K 44,951
2017-05-16 Presnell Sharon Collins Chief Scientific Officer Shares withheld for taxes −1,167 $2.86 $3K 99,188
2017-04-24 CROUCH TAYLOR CEO & President Grant or award · Stock Option (Right to Buy) +2,088,212 2,088,212
2017-02-16 Presnell Sharon Collins Chief Scientific Officer Shares withheld for taxes −1,390 $2.95 $4K 115,355
2017-02-16 Murphy Keith Chairman, CEO and President Shares withheld for taxes −5,742 $2.95 $17K 6,038,173
2017-02-16 Gallant Paul General Manager Shares withheld for taxes −1,320 $2.95 $4K 44,055
2017-02-16 David Eric CSO & EVP Pre-Clinical Dev Shares withheld for taxes −1,390 $2.95 $4K 701,966
2017-02-16 Bush Jennifer General Counsel & Secretary Shares withheld for taxes −1,390 $2.95 $4K 46,186
2017-02-09 Murphy Keith Chairman, CEO and President Sale −25,000 $3.68 $92K 6,043,915
2017-02-08 Murphy Keith Chairman, CEO and President Option exercise +30,000 $1.00 $30K 6,068,915
2017-02-08 Murphy Keith Chairman, CEO and President Option exercise · Warrant −30,000 0
2017-01-24 Murphy Keith Chairman, CEO and President Sale −20,100 $3.50 $70K 6,038,915

Page 9 of 13 · 259 trades